Form 4: Acelyrin Director Daniel J. Becker Acquires Stock Options
SEC Form 4 Filing
Director Daniel J. Becker acquired stock options in Acelyrin, Inc. on June 7, 2024.
Summary
- On June 7, 2024, Daniel J. Becker, a director of Acelyrin, Inc., acquired 92,158 stock options at a price of $4.46.
- These options vest on the earlier of June 7, 2025, or the day before the next annual meeting of stockholders, contingent upon continued service as a director.
- Following this transaction, Becker directly owns 92,158 derivative securities.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing, indicating a standard transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the holdings and transactions of company insiders.
Stakeholder Impact
- The acquisition of stock options by a director can be viewed positively by shareholders as it aligns the director's interests with the company's long-term success.
Key Dates
| Date | Description |
|---|---|
| 06/07/2024 | Date of transaction: Director Stock Option (right to buy) acquired |
| 06/07/2025 | Vesting date of the stock options, contingent on continued service as a director, or the day immediately preceding the next annual meeting of stockholders |
| 06/06/2034 | Expiration date of the stock options |
| 06/11/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.